Referring to meningiomas as “benign” overlooks the serious risks they pose, much like calling a ticking time bomb harmless just because it hasn’t exploded yet. While many women with meningiomas may initially do well, these tumors can silently grow, pressuring vital brain areas and leading to seizures, vision loss, and cognitive impairments.
Even when surgery successfully removes the tumor, the aftermath can be devastating—chronic headaches, emotional challenges, and the need for ongoing medication. Full recovery may take months, and continuous monitoring is required to ensure the tumor does not return. The Depo-Provera litigation underscores that, whether benign or malignant, the harm caused by these tumors is undeniable, and pharmaceutical companies must be held accountable for failing to warn patients about these dangers.
